| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > The Four Cs of Teamwork |
|
Digg It - The Four Cs of Teamwork
There is more than one version of The Four Cs of Teamwork. Jon R. Katzenbach proposed that they were communication, cooperation, collaboration and compromise whereas Lou Carloni suggested communication, cooperation, According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product contribution and commitment. In either case analysing a team’s position on the four Cs is a useful exercise and these two examples have communication and cooperation in common. Perhaps we should settle on six Cs of T ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in amwork. Communication Katzenbach and Carloni both agreed that good communication was an essential ingredient of teamwork. Arguably communication is at the core of all processes within business. The basics of commun lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ication require that roles and responsibilities are discussed and assigned within the team and that information is effectively shared. Beyond this you must ask whether disagreements and conflicts are constructively h here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ndled and finally whether team members are open and honest. Trust is the key to effective teamwork. Cooperation Good teamwork requires that team members cooperate fully with each other. Cooperation is a result of g d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro od communication and it requires clarity and, crucially, trust. Effective cooperation should be a harmonious process and again the quality of communication will determine this. A measure of cooperation is that when a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc member of a team is under pressure others offer to help out and the key word is offer. Begrudgingly lending a hand having been told to do so is not the same. Collaboration It is quite difficult to differentiate be easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ween cooperation and collaboration. The definition of both words have much in common. Cooperation is more commonly used to describe an association of people for economic gain. Collaboration is typically an intellectu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically l effort and it can also describe a treasonable association, for example with an enemy. It may suggest a form of very close and committed teamwork, but in this particular case I feel it is the weakest, or the least u and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ seful of the Cs. Compromise Compromise is very important in any relationship. It is rare for any outcome to be perfect; it is important that team members accept this and do not put colleagues under pressure particu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi arly when a best effort is acceptable. There are conditions when perfectionism is necessary for example in engineering or when a less than perfect outcome presents danger. However, one of the most debilitating behavi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a urs within a group effort is unnecessary nit picking or arguing over detail when it causes the team to lose focus on the objective. Contribution In most teams each individual will contribute a different set of skil dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ls to the group effort. The team must understand the role of each team member and they must understand how it contributes to the team’s objectives. Ideally everyone will understand and recognise the importance of eac cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin colleague’s skills. If one team member is perceived as being less important or not working as hard as others this will be a problem. If this is an issue between two colleagues the problem will need to be addressed b tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the team leader. If the feeling is a general consensus then serious questions need to be asked of the team member whose contribution is being questioned. Commitment Is the team committed to a common objective? Is t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the team, and particularly the leadership, committed to developing the individuals within the team? Are team members committed to one and other and do they share common values regarding the work they are doing? The f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rst step towards encouraging commitment within a team is to make sure that they understand their objectives and how those objectives fit into the goals of the whole company. Teams need to know that the work that they y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products are doing is important and valued elsewhere in the company. How can you use this information to the benefit of your team? Like many such theories this is essentially a discussion piece. You can take each word in tu . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rn and throw it out to your team members in an open session for discussion. Your objective is to see what issues come out of the discussion. You may find that other words and ideas come out of the discussion and you elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ay find that there are other words which are more relevant to your team. There are also some useful online surveys based around this; again they are designed to stimulate discussion rather than reach a set conclusion tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Market To Women, & How Should You Do It? Projector Remotes - Get Close To Your Audience
|